85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-020688-18-GB (EUCTR)	29/06/2011	28/01/2011	Safety and Efficacy of QAX576 in Patients With Progressive Idiopathic Pulmonary Fibrosis (IPF)	A randomized, double-blind, placebo-controlled, multipledose, exploratory proof of concept study to ...	Patients with rapidly progressive idiopathic pulmonary fibrosis MedDRA version: 14.1;Level: PT;Class ...	Product Code: QAX576	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	40		United Kingdom
2	NCT01266135 (ClinicalTrials.gov)	December 2010	17/12/2010	Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)	Randomized, Double-blind, Placebo-controlled, Multiple-dose, Exploratory Proof of Concept Study to A ...	Idiopathic Pulmonary Fibrosis	Drug: QAX576;Drug: Placebo	Novartis Pharmaceuticals	NULL	Terminated	18 Years	80 Years	All	40	Phase 2	United States;United Kingdom
3	NCT00532233 (ClinicalTrials.gov)	September 2007	19/9/2007	SD, IL-13 Production Rate in IPF	A Open-label, Multicenter Study, With a Single Intravenous Dose of QAX576to Determine IL-13 Producti ...	Idiopathic Pulmonary Fibrosis	Drug: QAX576	Novartis Pharmaceuticals	NULL	Completed	40 Years	80 Years	All	52	Phase 2	United States

First Previous1Next Last